company background image
E2OM logo

STRATA Skin Sciences DB:E2OM Stock Report

Last Price

€0.39

Market Cap

€15.4m

7D

-8.0%

1Y

-54.9%

Updated

20 Mar, 2024

Data

Company Financials +

STRATA Skin Sciences, Inc.

DB:E2OM Stock Report

Market Cap: €15.4m

E2OM Stock Overview

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.

E2OM fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

STRATA Skin Sciences, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for STRATA Skin Sciences
Historical stock prices
Current Share PriceUS$0.39
52 Week HighUS$1.03
52 Week LowUS$0.27
Beta1.61
1 Month Change-6.67%
3 Month Change-31.83%
1 Year Change-54.94%
3 Year Change-72.00%
5 Year Change-84.86%
Change since IPO-99.88%

Recent News & Updates

Recent updates

Shareholder Returns

E2OMDE Medical EquipmentDE Market
7D-8.0%-2.2%0.07%
1Y-54.9%3.4%4.9%

Return vs Industry: E2OM underperformed the German Medical Equipment industry which returned 6.7% over the past year.

Return vs Market: E2OM underperformed the German Market which returned 5% over the past year.

Price Volatility

Is E2OM's price volatile compared to industry and market?
E2OM volatility
E2OM Average Weekly Movement14.5%
Medical Equipment Industry Average Movement4.6%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.5%

Stable Share Price: E2OM's share price has been volatile over the past 3 months.

Volatility Over Time: E2OM's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
1989114Dolev Rafaelihttps://www.strataskinsciences.com

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions.

STRATA Skin Sciences, Inc. Fundamentals Summary

How do STRATA Skin Sciences's earnings and revenue compare to its market cap?
E2OM fundamental statistics
Market cap€15.41m
Earnings (TTM)-€6.59m
Revenue (TTM)€32.29m

0.5x

P/S Ratio

-2.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
E2OM income statement (TTM)
RevenueUS$35.27m
Cost of RevenueUS$14.76m
Gross ProfitUS$20.51m
Other ExpensesUS$27.70m
Earnings-US$7.20m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Mar 27, 2024

Earnings per share (EPS)-0.21
Gross Margin58.14%
Net Profit Margin-20.40%
Debt/Equity Ratio92.7%

How did E2OM perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.